H

Hartalega Holdings Bhd
KLSE:HARTA

Watchlist Manager
Hartalega Holdings Bhd
KLSE:HARTA
Watchlist
Price: 1.18 MYR 4.42% Market Closed
Market Cap: 4B MYR

EV/OCF

7.7
Current
117%
Cheaper
vs 3-y average of -46.4

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
7.7
=
Enterprise Value
MYR2.1B
/
Operating Cash Flow
384.8m

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
7.7
=
Enterprise Value
MYR2.1B
/
Operating Cash Flow
384.8m

Valuation Scenarios

Hartalega Holdings Bhd is trading above its 5-year average

If EV/OCF returns to its 5-Year Average (3.7), the stock would be worth MYR0.56 (52% downside from current price).

Statistics
Positive Scenarios
2/3
Maximum Downside
-52%
Maximum Upside
+54%
Average Upside
18%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 7.7 MYR1.18
0%
5-Year Average 3.7 MYR0.56
-52%
Industry Average 11.7 MYR1.79
+51%
Country Average 11.9 MYR1.82
+54%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close
Market Cap EV/OCF P/E
MY
Hartalega Holdings Bhd
KLSE:HARTA
4B MYR 7.7 52.3
US
Medline Inc
NASDAQ:MDLN
58.8B USD 0 0
JP
Hoya Corp
TSE:7741
9.7T JPY 36.2 38.6
CH
Alcon AG
SIX:ALC
29.2B CHF 17.4 37.3
DK
Coloplast A/S
CSE:COLO B
94.7B DKK 16.5 23.5
US
Align Technology Inc
NASDAQ:ALGN
13.5B USD 20.9 33
UK
ConvaTec Group PLC
LSE:CTEC
4.3B GBP 15.2 32.7
CA
Bausch + Lomb Corp
NYSE:BLCO
5.6B USD 36.2 -15.5
JP
Asahi Intecc Co Ltd
TSE:7747
890.2B JPY 20.8 50.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
36.7B CNY 24.7 23.3
KR
HLB Inc
KOSDAQ:028300
8T KRW -86.3 -36.2
P/E Multiple
Earnings Growth PEG
MY
H
Hartalega Holdings Bhd
KLSE:HARTA
Average P/E: 36.4
52.3
32%
1.6
US
M
Medline Inc
NASDAQ:MDLN
Not Available
30%
N/A
JP
Hoya Corp
TSE:7741
38.6
15%
2.6
CH
Alcon AG
SIX:ALC
37.3
32%
1.2
DK
Coloplast A/S
CSE:COLO B
23.5
21%
1.1
US
Align Technology Inc
NASDAQ:ALGN
33
34%
1
UK
ConvaTec Group PLC
LSE:CTEC
32.7
41%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.5 N/A N/A
JP
A
Asahi Intecc Co Ltd
TSE:7747
50.3
40%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.3
9%
2.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -36.2 N/A N/A

Market Distribution

In line with most companies in Malaysia
Percentile
31st
Based on 364 companies
31st percentile
7.7
Low
0.3 — 7.4
Typical Range
7.4 — 19.2
High
19.2 —
Distribution Statistics
Malaysia
Min 0.3
30th Percentile 7.4
Median 11.9
70th Percentile 19.2
Max 44 111.4

Hartalega Holdings Bhd
Glance View

Hartalega Holdings Bhd, founded in 1988 by Kuan Kam Hon, embarked on its journey as a modest manufacturer of latex gloves, driven by the compelling vision of transforming the glove industry through technological innovation and stringent quality standards. Situated in Malaysia, a key hub of rubber production, Hartalega rapidly carved out a niche for itself by focusing on high-efficiency production and sustainability. The company pioneered the introduction of its flagship product, the world’s first lightweight nitrile glove, in response to increasing global demand for more durable and allergy-free alternatives to latex gloves. This innovation positioned Hartalega as a leader in the medical glove market, enabling it to cater to diverse sectors such as healthcare, food, and industrial applications. Operational excellence lies at the heart of Hartalega’s business model. The company leverages advanced automated production facilities that minimize waste and optimize output, driving down costs while boosting quality. By investing heavily in research and development, Hartalega continuously enhances its product offerings, maintaining a competitive edge in an industry characterized by rapidly shifting dynamics. Revenue streams are bolstered by a robust global distribution network that ensures the versatility and availability of their products to satisfy international demands. In this thriving ecosystem, Hartalega's commitment to innovation and sustainability plays a crucial role not only in bolstering its financial performance but also in reinforcing its enduring partnership with clients around the world, shaping the future of hand protection one glove at a time.

HARTA Intrinsic Value
1.12 MYR
Overvaluation 5%
Intrinsic Value
Price MYR1.18
H
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett